Biofarma Taps Checo Pérez for a Sustainable Wellness Push

MEXICO CITY – May 20, 2026 – Mexican pharmaceutical company Laboratorios Biofarma is revving its engines for a major push into the booming wellness market, combining the star power of Formula 1 driver Sergio "Checo" Pérez with a newly awarded Corporate Social Responsibility (CSR) distinction. The Guadalajara-based laboratory announced today it is launching SP Humania, a line of supplements developed with Pérez, while simultaneously committing to a sweeping sustainability strategy.

This dual announcement signals a calculated move by the 30-year-old company to differentiate itself in a crowded field, leveraging a high-profile athlete endorsement alongside a verifiable commitment to environmental and social ethics.

A New Formula: Celebrity and Conscience

The partnership with Sergio Pérez, one of Mexico's most celebrated international athletes, is central to Biofarma's market strategy. The SP Humania brand is the result of a year-long collaboration that began when the driver's team sought a scientifically robust partner to create a wellness line.

According to the company's business development manager, Juan Pedro Luna, the project was conceived to build a brand linked not only to Pérez's high-performance career but also to his personal values. The goal was to create "something that could transcend Formula 1 with the support of a trusted laboratory with scientific expertise."

This collaboration places Biofarma directly into the rapidly growing, multi-billion dollar Mexican supplement market. For a company with over three decades of experience in pharmaceuticals and herbal remedies, the move is a significant expansion into the consumer wellness space.

"The laboratory... has more than 30 years of experience specializing in the manufacturing, commercialization, and development of new medicines, supplements, and herbal remedies," said Claudia Selene Chávez, the company's director general. She framed the recent CSR recognition as a pivotal moment, stating it "represents much more than a badge for the company," as it involves a deep review of internal processes and new commitments.

Beyond the Badge: Sustainability in the Spotlight

The CSR distinction awarded to Biofarma is not just a marketing tool but a reflection of a broader corporate pivot towards sustainability. The company's strategy includes concrete initiatives aimed at transforming its value chain. Key among these are a transition to more biodegradable and sustainable packaging and the exploration of renewable energy sources to minimize the environmental footprint of its manufacturing operations in Jalisco.

This focus on environmental, social, and governance (ESG) principles is particularly timely. Beginning in 2026, many Mexican companies will face new mandatory sustainability disclosure standards, requiring them to report on climate-related risks and other ESG metrics. Biofarma's proactive steps position it ahead of this regulatory curve, turning compliance into a competitive advantage.

Beyond its environmental goals, the company has reinforced its social commitments. Chávez highlighted that Biofarma has long promoted product donations to vulnerable populations across Mexico, a practice she described as integral to its "vision of social responsibility and its commitment to addressing health needs in various communities."

This public commitment to ethical practices provides a powerful narrative to complement the high-octane appeal of its new brand ambassador, creating a story that resonates with modern consumers who increasingly prioritize transparency and corporate accountability.

Navigating Mexico's Booming Supplement Market

Biofarma and SP Humania are entering a dynamic but fiercely competitive landscape. The Mexican dietary supplements market is projected to grow at a compound annual growth rate (CAGR) of over 7% through 2030, with some estimates projecting the market value to surpass $14 billion by the end of the decade. This surge is driven by a post-pandemic focus on preventive health, rising disposable incomes, and a growing interest in active nutrition.

However, this growth has created an information-saturated environment where consumers are bombarded with wellness products. International giants like Herbalife and GNC compete alongside strong local players, all vying for consumer trust and loyalty.

Biofarma's marketing manager, Natalia Gamboa, acknowledged this challenge, noting that the boom in wellness products has made it essential to offer more than just clever marketing. "Promises alone are no longer enough," she stated. "You have to be able to say: there is science behind this."

The 'Science-Backed' Promise

The company's emphasis on scientific validation is its intended cornerstone for building credibility. Biofarma asserts that its formulas are developed by specialized teams and meticulously comply with Mexican health regulations. This is a critical claim in a sector overseen by the Federal Commission for the Protection against Sanitary Risks (COFEPRIS).

COFEPRIS enforces strict rules for food supplements, which are prohibited from making any therapeutic, preventive, or medicinal claims. All labeling, ingredients, and advertising must receive prior approval to ensure they are truthful and do not mislead consumers. For SP Humania, this means any marketing—whether from Pérez or the company—will need to carefully navigate these regulations, focusing on supporting general wellness and dietary intake rather than promising specific health outcomes.

By pairing the global appeal and trusted image of Checo Pérez with a stated commitment to scientific rigor and corporate responsibility, Biofarma is making a strategic bet. The company aims to prove that a combination of celebrity influence, ethical operations, and verifiable product quality is the winning formula for success in Mexico's evolving health and wellness race.